Wednesday, 22 March 2023

Malaysian Genomics explores R&D collaboration with SIRIM

10 January 2023 | News

Group enters into strategic cooperation for projects in the medical and biotechnology fields

image credit- istock

image credit- istock

Malaysian Genomics Resource Centre Berhad , a leading genomics and biopharmaceutical specialist,  has announced a strategic cooperation with SIRIM Berhad, to explore the commercialisation of joint research and development (R&D) projects in the medical and biotechnology fields.

SIRIM Berhad is wholly owned by the Malaysian Government, and is focused on R&D, standardisation and quality. The organisation acts as a catalyst for industrial development through programmes involving technology and standardisation.

Under the strategic cooperation, both parties will evaluate the potential commercial value of a range of genomics-driven biotechnology R&D projects. These include developing biofuels and biopharmaceuticals, companion diagnostic tests for cancer treatment, and bioactive cosmeceuticals.

This two-year strategic collaboration will also jointly source for suitable private and public institutional partners for the funding and commercialisation of these projects.

Sign up for the editor pick and get articles like this delivered right to your inbox.

Editors Pick
+Country Code-Phone Number(xxx-xxxxxxx)


× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account